Showing results (2111-2120 of 2,257) with videos related to

Sort By:
Pageof 226
Malaria Journal|January 5, 2020
The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDRKoukeo Phommasone, Frank van Leth, Mallika Imwong, et al.
The Lancet. Planetary Health|November 14, 2021
Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling studyAnnie J Browne, Michael G Chipeta, Georgina Haines-Woodhouse, et al.
International Health|March 20, 2025
Understanding the primary healthcare context in rural South and Southeast Asia: a village profiling studyRusheng Chew, Sazid Ibna Zaman, Mst Asfat Ara Joly, et al.
Veterinary Pathology|April 22, 2008
Histopathologic, immunohistochemical, and cytologic analysis of feline myeloma-related disorders: further evidence for primary extramedullary development in the catP J Mellor, S Haugland, K C Smith, et al.
The Lancet Regional Health. Western Pacific|July 18, 2022
Evaluation of trends in hospital antimicrobial use in the Lao PDR using repeated point-prevalence surveys-evidence to improve treatment guideline useVilada Chansamouth, Danoy Chommanam, Tamalee Roberts, et al.
NPJ Vaccines|July 6, 2024
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adultsBorimas Hanboonkunupakarn, Mavuto Mukaka, Podjanee Jittamala, et al.
Plos One|November 24, 2011
Timing of enteral feeding in cerebral malaria in resource-poor settings: a randomized trialRichard J Maude, Gofranul Hoque, Mahtab Uddin Hasan, et al.
The Journal of Infectious Diseases|November 7, 2019
Reduced Cardiac Index Reserve and Hypovolemia in Severe Falciparum MalariaHugh W F Kingston, Aniruddha Ghose, Voravut Rungpradubvong, et al.
Nature Communications|November 12, 2014
The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptorsAndrás N Spaan, Manouk Vrieling, Pierre Wallet, et al.
Communications Biology|August 3, 2019
A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolitesShaowei Zhang, Michiyo Sakuma, Girdhar S Deora, et al.
Pageof 226